E2F1 and breast carcinoma: In addition, the data from an online database indicated that miR-320a could bind to the 3′-UTR of E2F1, which is a well-known transcriptional activator that has been determined to be extensive involved in tumour progression in such cancers as bladder cancer 42 breast cancer 43, and lung cancer 44.